VPIM
BDTX icon

Vanguard Personalized Indexing Management’s Black Diamond Therapeutics BDTX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.1K Buy
+10,380
New +$24.7K ﹤0.01% 2117
2025
Q2 		– Sell
-10,980
Closed -$17K – 1953
2025
Q1 		$17K Buy
+10,980
New +$23K ﹤0.01% 1790

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vanguard Personalized Indexing Management's BDTX Position: Q1 2026 in Review

Vanguard Personalized Indexing Management opened a new position in Black Diamond Therapeutics (BDTX) in Q1 2026: 10,380 shares worth $22.1K. The stake represents ﹤0.01% of the portfolio and ranks #2117 among its holdings. This is a return to the name: Vanguard Personalized Indexing Management previously reported a position in BDTX as recently as Q1 2025.

Vanguard Personalized Indexing Management first reported a position in BDTX in Q1 2025 and has held it in 2 quarters since. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • Vanguard Personalized Indexing Management held 10,380 shares of Black Diamond Therapeutics worth $22.1K as of Q1 2026.
  • Black Diamond Therapeutics was a new Vanguard Personalized Indexing Management position in Q1 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2117 holding.
  • Vanguard Personalized Indexing Management first reported a position in Black Diamond Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.